Zevia insider files to sell 2.97M Class A shares via BMO Capital Markets

Rhea-AI Filing Summary

Zevia PBC (ZVIA) Form 144 notice shows a proposed sale of 2,971,664 Class A shares through BMO Capital Markets on 09/30/2025 on the NYSE, with an aggregate market value of $8,112,642.72. The filing reports total Class A shares outstanding of 67,318,542. The shares were acquired on 12/21/2020 via a purchase of Series E preferred units in Zevia LLC that converted to Class A common stock at the issuer's IPO; the acquisition was paid in cash and the filer received 22,022,092 shares in that transaction. The filer reports no securities sold in the past three months and provides the required Rule 144 attestation.

Positive

• Full provenance disclosed: The filing states the shares originated from a 12/21/2020 purchase of Series E preferred units that converted at IPO.
• Transaction paid in cash: The acquisition is reported as paid in cash, clarifying consideration.
• No recent sales: The filer reports no securities sold in the past three months.

Negative

• Large proposed sale: 2,971,664 shares equal approximately 4.42% of the reported 67,318,542 shares outstanding, which is a material single-block disposition.
• Potential supply impact: The $8.11 million aggregate sale could increase share supply on the announced sale date.

Insights

Securities Analyst

TL;DR: A significant insider-related sale is planned that represents a single-digit percentage of outstanding stock; disclosure is routine under Rule 144.

The filing documents a proposed Rule 144 sale of 2.97 million Class A shares valued at $8.11 million via BMO Capital Markets on 09/30/2025. That quantity equals approximately 4.42% of the reported 67.32 million shares outstanding, a non-trivial block for a public float. The shares trace to a December 21, 2020 purchase of Series E preferred units that converted at IPO and were paid for in cash. No sales were reported in the past three months, and the filer makes the standard attestation regarding material non-public information.

Corporate Governance Specialist

TL;DR: Filing is a standard Rule 144 disclosure; it documents provenance of shares and an imminent market disposition.

The notice appropriately identifies the broker, intended sale date, and the origin of the securities (conversion of Series E preferred units acquired in 2020). The conversion origin and cash payment are explicitly disclosed, which helps clarify the filer’s ownership basis. The document contains no additional governance or control changes and reports no recent sales by the filer in the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A common stock	BMO Capital Markets 151 W 42nd St New York NY 10036	2971664	8112642.72	67318542	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	12/21/2020	Purchase of Series E Preferred Units in Zevia LLC in December 2020, which were ultimately converted into the issuer's Class A common stock in connection with the issuer's IPO.	Zevia PBC			22022092	12/21/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Zevia's (ZVIA) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 2,971,664 Class A shares via BMO Capital Markets on 09/30/2025 with an aggregate market value of $8,112,642.72 on the NYSE.

How many Zevia shares are outstanding and what percentage is being offered?

The filing reports 67,318,542 Class A shares outstanding; the proposed sale of 2,971,664 shares is approximately 4.42% of that total.

When and how were the shares being sold acquired?

The shares were acquired on 12/21/2020 through a purchase of Series E preferred units in Zevia LLC that later converted into Class A common stock at the issuer's IPO; the acquisition was paid in cash.

Did the filer sell any Zevia securities in the prior three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale?

The proposed sale lists BMO Capital Markets at 151 W 42nd St, New York, NY, as the broker of record.